Editors choice in Science Translational Medicine: Mitochondria fragments fuel the fire of neuroinflammation, by Gilbert Gallardo
“1 method may prevent brain cell death in several diseases” Brude Goldman from Stanford University writes about a collaboration with Daria Mochly-Rosen’s group at Stanford - an extension of our original A1 work published in Nature.
A short podcast where Shane discusses astrocytes and Alzheimer’s disease—a topic he also spoke about at the Alzheimer's Association International Conference 2019.
Shane win’s the Inge Grundke-Iqbal Award for Alzheimer’s Research - awarded for most impactful study published in Alzheimer’s research during the preceding two calendar years. Read the press release here.
“Clearing the Fog surrounding Chemobrain” David Gutman from WashU St Louis writes a fantastic summary of our collaboration with Michelle Monje at Stanford University. Learn more about ChemoBrain here.
How does chemo brain work? One cancer drug might interfere with brain signaling. A brief highlight about our work in collaboration with Erin Gibson and Michelle Monje at Stanford in Science by Jennifer Couzin-Frankel.
Scientists discover a probable cause of 'chemo brain' and it may be treatable writes Victoria Forster in Forbes.
‘Chemo brain’ caused by malfunction in three types of brain cells writes Erin Digitale for the Stanford Medicine News Center. See also her piece for SCOPE - New hope for treating “chemo brain,” with a side of the joy of science.
'Chemo brain' may result from effects on 'helper cells.' The finding could lead to possible treatments. Rachel Rettner, senior writer at LiveScience explains the key concepts of glial cell interactions following chemotherapy.
Esther Landhuis writes an exciting piece about astrocytes in this Technology Feature in Nature - Tapping into the brain’s star power. Graduate Student Rachel Kim’s stunning immunopanned astrocyte is highlighted at the start of the article!
Neuroimmunology Experts Survey written by Benjamin Stecher - an amazing patient advocate and force behind the Tomorrow Edition.
Is a cure for Parkinson's on the horizon? Experimental drug STOPS its progress and can combat its symptoms, promising trials show. Stephen Matthews for Mail Online.
Drug that stops progression of Parkinson's disease heads for human trials: read about how astrocytes may be a drug target to treat Parkinson’s disease. By Richard Haridy from New Atlas.
Experimental drug stops Parkinson’s Disease progression in mice: A great press release on our recent work with the Dawson Lab from Johns Hopkins.
Compound similar to diabetic medications slows parkinson’s progression in mouse study: Jose Marques Lopes writes about our collaboration with the Dawson Lab from Johns Hopkins in Parkinson’s News Today.
Does Taming Killer Astrocytes Spare Neurons in Parkinson’s Disease? - Pat McCaffrey from AlzForum writes writes about our aging astrocytes collaboration with the Dawson lab at Johns Hopkins University.
Rachel Kim wins a prestigious National Science Foundation Graduate Research Fellowship.
Interview With Astrocyte Expert Prof. Shane Liddelow - Benjamin Stecher from the Tomorrow Edition and I had a chat about astrocytes. Check out his website for more great interviews about Parkinson's disease and associated disorders.
Aged Astrocytes Prime Brain for Neuroinflammation - Madolyn Rogers from AlzForum writes writes about our aging astrocytes collaboration with Laura Clarke at Stanford.
Star-shaped brain cells called astrocytes implicated in brain’s aging process, Stanford study shows. Bruce Goldman writes about our new collaboration with Laura Clarke at Stanford.
Astrocytic IL-33 Signals Microglia to Engulf Synapses - Madolyn Rogers from AlzForum discusses the microglia-astrocyte control of synaptic pruning. A collaboration with Anna Molofsky from UCSF.
STATNews names Shane Liddelow as one of 26 'Wunderkinds' for 2017.
Cover image for Immunity special edition on the Neuro-Immune Axis.
Is this the Alzheimer's gene? A nice piece on the DailyMail website about our collaboration with David Holtzman at Washington University in St Louis.
ApoE4 Makes All Things Tau Worse, From Beginning to End - AlzForum.
An Ancient Cure for Alzheimer’s? Pagan Kennedy wrote an op-ed that included some of our work in the New York Times.
For the non-scientists, how about something a little more accessible? Try this Science Breaker piece - Toxic brain cells are a new target for treating neurodegeneration.
Astrocytes as ‘Villainous Characters’. Carolyn Gregoire wrote about our work in the Huffington Post.
Michelle Pflumm writes "Microglia May Turn Astrocytes to the Dark Side in ALS" on the ALS Research Forum - an overview of our 2017 Nature paper.
Toxic brain cells may drive many neurodegenerative disorders. Bruce Goldman wrote a wonderful piece for the Stanford University News Center on our reactive astrocyte paper.